Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis
- 30 June 1995
- journal article
- review article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 22 (1-2) , 141-145
- https://doi.org/10.1016/0732-8893(95)00089-s
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosisHepatology, 1994
- Spontaneous bacterial peritonitis in liver cirrhosis: Treatment and prophylaxisInfection, 1994
- Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patientsAntimicrobial Agents and Chemotherapy, 1993
- Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patientsHepatology, 1991
- Amoxicillin–Clavulanic Acid Therapy of Spontaneous Bacterial Peritonitis: A Prospective Study of Twenty–Seven Cases in Cirrhotic PatientsHepatology, 1990
- Evaluation of aztreonam in the treatment of spontaneous bacterial peritonitis in patients with cirrhosisHepatology, 1986
- Cefotaxime Is More Effective Than Is Ampicillin–Tobramycin in Cirrhotics With Severe InfectionsHepatology, 1985
- The Diagnosis of Bacterial Peritonitis: Comparison of Ph, Lactate Concentration and Leukocyte CountHepatology, 1985
- Cefotaxime A review of its Antibacterial Activity, Pharmacological Properties and Therapeutic UseDrugs, 1983
- Aminoglycoside nephrotoxicity in cirrhosisGastroenterology, 1982